News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Daily News IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC Michael O'Riordan November 11, 2024
News Conference News TCT 2024 PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE Todd Neale October 29, 2024
News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News ISET 2024 AI in Pulmonary Embolism: ‘Transformative’ for Patient Care Caitlin E. Cox January 30, 2024
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE Todd Neale October 19, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty Todd Neale August 25, 2022
News Daily News Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax Michael O'Riordan February 23, 2022
News Daily News DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis L.A. McKeown January 20, 2022
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News TCT 2021 FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results Todd Neale November 03, 2021
News Daily News SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE Todd Neale June 23, 2021